Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Adamas Pharmaceuticals Inc
| Metric | Adamas Pharmaceuticals Inc Healthcare |
|---|---|
| Quality Score | 49 / 100 |
| Revenue (latest) | $74M |
| Net income (latest) | −$57M |
| Operating margin | −59.3% |
| Net margin | −77.1% |
| Return on equity | 114.9% |
| Return on assets | −47.8% |
| Return on capital (ROCE) | −51.9% |
| Debt / equity | — |
| Revenue growth (YoY) | 36.3% |
| Altman Z″ (distress) | -12.30 |
| Accruals / assets | −5.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.